Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma

Renal cell carcinoma encompass distinct diseases with different pathologic features and distinct molecular pathways. Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway alone or in combination have greatly changed clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kammerer-Jacquet, Solène-Florence, Deleuze, Antoine, Saout, Judikaël, Mathieu, Romain, Laguerre, Brigitte, Verhoest, Gregory, Dugay, Frédéric, Belaud-Rotureau, Marc-Antoine, Bensalah, Karim, Rioux-Leclercq, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480014/
https://www.ncbi.nlm.nih.gov/pubmed/30987368
http://dx.doi.org/10.3390/ijms20071692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480014/
https://www.ncbi.nlm.nih.gov/pubmed/30987368
http://dx.doi.org/10.3390/ijms20071692

Ejemplares similares